Skip to main content
SpringerLink
Log in

Filaggrin, the Skin Barrier, and Diabetes

  • Chapter
  • First Online:
Filaggrin

Abstract

Diabetes is a prevalent disease with a remarkably amount of skin involvement. About 30 % of patients have dermatological manifestations, and these can be the first sign of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.

    Article  PubMed  Google Scholar 

  2. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10:861–8.

    Article  Google Scholar 

  3. Seirafi H, Farsinejad K, Firooz A, Davoudi SM, Robati RM, Hoseini MS, et al. Biophysical characteristics of skin in diabetes: a controlled study. J Eur Acad Dermatol Venereol. 2009;23:146–9.

    Article  CAS  PubMed  Google Scholar 

  4. Wahid Z, Kanjee A. Cutaneous manifestations of diabetes mellitus. J Pak Med Assoc. 1998;48:304–5.

    CAS  PubMed  Google Scholar 

  5. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012;26:1203–11.

    Article  CAS  PubMed  Google Scholar 

  6. Franzen LE, Roberg K. Impaired connective tissue repair in streptozotocin-induced diabetes shows ultrastructural signs of impaired contraction. J Surg Res. 1995;58:407–14.

    Article  CAS  PubMed  Google Scholar 

  7. Bitar MS. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am J Pathol. 1998;152:547–54.

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Park HY, Kim JH, Jung M, Chung CH, Hasham R, Park CS, et al. A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol. 2011;20:969–74.

    Article  CAS  PubMed  Google Scholar 

  9. Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J, Cardenas A, et al. Expression of antimicrobial peptides in diabetic foot ulcer. J Dermatol Sci. 2012;65:19–26.

    Article  CAS  PubMed  Google Scholar 

  10. Sakai S, Endo Y, Ozawa N, Sugawara T, Kusaka A, Sayo T, et al. Characteristics of the epidermis and stratum corneum of hairless mice with experimentally induced diabetes mellitus. J Invest Dermatol. 2003;120:79–85.

    Article  CAS  PubMed  Google Scholar 

  11. Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol. 2005;153:319–23.

    Article  CAS  PubMed  Google Scholar 

  12. Chen XF, Lin WD, Lu SL, Xie T, Ge K, Shi YQ, et al. Mechanistic study of endogenous skin lesions in diabetic rats. Exp Dermatol. 2010;19:1088–95.

    Article  CAS  PubMed  Google Scholar 

  13. Thyssen JP, Linneberg A, Carlsen BC, Johansen JD, Engkilde K, Hansen T, et al. A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open. 2011;1:e000062.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Prokopenko I, Zeggini E, Hanson RL, Mitchell BD, Rayner NW, Akan P, et al. Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q. Diabetes. 2009;58:1704–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Jelinek JE. The skin in diabetes. Diabet Med. 1993;10:201–13.

    Article  CAS  PubMed  Google Scholar 

  16. Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol. 2003;69:105–8.

    CAS  PubMed  Google Scholar 

  17. Seite S, Khemis A, Rougier A, Ortonne JP. Importance of treatment of skin xerosis in diabetes. J Eur Acad Dermatol Venereol. 2011;25:607–9.

    Article  CAS  PubMed  Google Scholar 

  18. Yamaoka H, Sasaki H, Yamasaki H, Ogawa K, Ohta T, Furuta H. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010;33:150–5.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Pavlovic MD, Milenkovic T, Dinic M, et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care. 2007;30:1964–7.

    Article  PubMed  Google Scholar 

  20. Garrigue E, Martini J, Cousty-Pech F, et al. Evaluation of the moisturizer Pedimed® in the foot care of diabetic patients. Diabetes Metab. 2011;37:330–5.

    Article  CAS  PubMed  Google Scholar 

  21. Sehgal VN, Bhattacharya SN, Verma P. Juvenile, insulin-dependent diabetes mellitus, type 1-related dermatoses. J Eur Acad Dermatol Venereol. 2011;25:625–36.

    Article  CAS  PubMed  Google Scholar 

  22. Litzelman DK, Marriott DJ, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Conventional wisdom or evidence-based practice? Diabetes Care. 1997;20:156–62.

    Article  CAS  PubMed  Google Scholar 

  23. Romano G, Moretti G, Di BA, Giofrè C, Di Cesare E, Russo G, et al. Skin lesions in diabetes mellitus: prevalence and clinical correlations. Diabetes Res Clin Pract. 1998;39:101–6.

    Article  CAS  PubMed  Google Scholar 

  24. Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998;21:506–9.

    Article  CAS  PubMed  Google Scholar 

  25. Pavicic T, Korting HC. Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management. J Dtsch Dermatol Ges. 2006;4:935–41.

    Article  PubMed  Google Scholar 

  26. Kennedy L, Baynes JW. Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia. 1984;26:93–8.

    Article  CAS  PubMed  Google Scholar 

  27. Sternberg M, Cohen-Forterre L, Peyroux J. Connective tissue in diabetes mellitus: biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabete Metab. 1985;11:27–50.

    CAS  PubMed  Google Scholar 

  28. Liao H, Zakhaleva J, Chen W. Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing. Biomaterials. 2009;30:1689–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Stern DM, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev. 2002;1:1–15.

    Article  CAS  PubMed  Google Scholar 

  30. Nakai K, Yoneda K, Ishihara Y, Ohmori K, Moriue T, Igarashi J, et al. Lipid peroxidation-induced VEGF expression in the skin of KKAy obese mice. Exp Dermatol. 2011;20:388–93.

    Article  CAS  PubMed  Google Scholar 

  31. Forst T, Kann P, Pfutzner A, Lobmann R, Schäfer H, Beyer J. Association between “diabetic thick skin syndrome” and neurological disorders in diabetes mellitus. Acta Diabetol. 1994;31:73–7.

    Article  CAS  PubMed  Google Scholar 

  32. Aoki Y, Yazaki K, Shirotori K, Yanagisawa Y, Oguchi H, Kiyosawa K, et al. Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress. Diabetologia. 1993;36:79–83.

    Article  CAS  PubMed  Google Scholar 

  33. Wertheimer E, Spravchikov N, Trebicz M, Gartsbein M, Accili D, Avinoah I, et al. The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology. 2001;142:1234–41.

    CAS  PubMed  Google Scholar 

  34. Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes. 2001;50:1627–35.

    Article  CAS  PubMed  Google Scholar 

  35. Sadagurski M, Yakar S, Weingarten G, Holzenberger M, Rhodes CJ, Breitkreutz D, et al. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol. 2006;26:2675–87.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Wertheimer E, Trebicz M, Eldar T, Gartsbein M, Nofeh-Moses S, Tennenbaum T. Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol. 2000;115:24–9.

    Article  CAS  PubMed  Google Scholar 

  37. Yoo H, Kim SJ, Kim Y, Lee H, Kim TY. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol. 2007;39:1248–59.

    Article  CAS  PubMed  Google Scholar 

  38. Li Y, Fan J, Chen M, Li W, Woodley DT. Transforming growth factor-alpha: a major human serum factor that promotes human keratinocyte migration. J Invest Dermatol. 2006;126:2096–105.

    Article  CAS  PubMed  Google Scholar 

  39. Benoliel AM, Kahn-Perles B, Imbert J, Verrando P. Insulin stimulates haptotactic migration of human epidermal keratinocytes through activation of NF-kappa B transcription factor. J Cell Sci. 1997;110(Pt 17):2089–97.

    CAS  PubMed  Google Scholar 

  40. Ando Y, Jensen PJ. Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J Invest Dermatol. 1993;100:633–9.

    Article  CAS  PubMed  Google Scholar 

  41. Sertznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol. 2008;9:15–31.

    Article  PubMed  Google Scholar 

  42. Cheta D. Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab. 1998;11:11–9.

    Article  CAS  PubMed  Google Scholar 

  43. Imokawa G, Kuno H, Kawai M. Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol. 1991;96:845–51.

    Article  CAS  PubMed  Google Scholar 

  44. Akimoto K, Yoshikawa N, Higaki Y, Kawashima M, Imokawa G. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol. 1993;20:1–6.

    CAS  PubMed  Google Scholar 

  45. Denda M, Hori J, Koyama J, Yoshida S, Nanba R, Takahashi M, et al. Stratum corneum sphingolipids and free amino acids in experimentally-induced scaly skin. Arch Dermatol Res. 1992;284:363–7.

    Article  CAS  PubMed  Google Scholar 

  46. Jo N, Watanabe M, Kiyokane K, Shimada M. In vivo microradioautographic study of insulin binding in the skin of normal and NIDDM mice: with special reference to acanthosis nigricans. Cell Mol Biol (Noisy-le-grand). 1997;43:157–64.

    CAS  Google Scholar 

  47. Toh YC. Effect of streptozotocin-induced diabetes on the activity of the sebaceous glands in rats. Endokrinologie. 1982;80:56–9.

    CAS  PubMed  Google Scholar 

  48. Paye M, Mac-Mary S, Elkhyat A, Tarrit C, Mermet P, Humbert PH. Use of the Reviscometer for measuring cosmetics-induced skin surface effects. Skin Res Technol. 2007;13:343–9.

    Article  CAS  PubMed  Google Scholar 

  49. Yoon HS, Baik SH, Oh CH. Quantitative measurement of desquamation and skin elasticity in diabetic patients. Skin Res Technol. 2002;8:250–4.

    Article  PubMed  Google Scholar 

  50. Goldschmidt H. Surface area measurements of psoriatic corneocytes: effects of intralesional steroid therapy. J Invest Dermatol. 1979;73:558–60.

    Article  CAS  PubMed  Google Scholar 

  51. Watanabe M, Tagami H, Horii I, Takahashi M, Kligman AM. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol. 1991;127:1689–92.

    Article  CAS  PubMed  Google Scholar 

  52. Corcuff P, Leveque J-L. Size and shape of corneocytes at various body sites: influence of age. In: Leveque J-L, editor. Aging skin. New York: Marcel Dekker; 1993. p. 199–216.

    Google Scholar 

  53. Hara M, Kikuchi K, Watanabe M, et al. Senile xerosis. Functional, morphological and biochemical studies. J Geriatr Dermatol. 1993;1:111–20.

    Google Scholar 

  54. Yajima Y, Sueki H, Fujisawa R. Increased corneocyte surface area in the diabetic skin. Nihon Hifuka Gakkai Zasshi. 1991;101:129–34.

    CAS  PubMed  Google Scholar 

  55. Jolly Jr HW, Hailey CW, Netick J. pH determinations of the skin. Readings under normal and abnormal conditions. J Invest Dermatol. 1961;36:305–8.

    CAS  PubMed  Google Scholar 

  56. Korting HC, Kober M, Mueller M, Braun-Falco O. Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. Acta Derm Venereol. 1987;67:41–7.

    CAS  PubMed  Google Scholar 

  57. De D, Handa S. Filaggrin mutations and the skin. Indian J Dermatol Venereol Leprol. 2012;78:545–51.

    Article  PubMed  Google Scholar 

  58. Yosipovitch G, Tur E, Cohen O, Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care. 1993;16:560–3.

    Article  CAS  PubMed  Google Scholar 

  59. Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 1989;7:531–46.

    CAS  PubMed  Google Scholar 

  60. Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris – the filaggrin mutation disease. Br J Dermatol. 2013;168(6):1155–66.

    Article  CAS  PubMed  Google Scholar 

  61. Saleh NM, Raj SM, Smyth DJ, Wallace C, Howson JM, Bell L, et al. Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes. Diabetes Metab Res Rev. 2011;27:838–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  62. Douek IF, Leech NJ, Gillmor HA, Bingley PJ, Gale EA. Children with type-1 diabetes and their unaffected siblings have fewer symptoms of asthma. Lancet. 1999;353:1850.

    Article  CAS  PubMed  Google Scholar 

  63. Decreased prevalence of atopic diseases in children with diabetes. The EURODIAB Substudy 2 Study Group. J Pediatr. 2000;137:470–4.

    Google Scholar 

  64. Olesen AB, Juul S, Birkebaek N, Thestrup-Pedersen K. Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet. 2001;357:1749–52.

    Article  CAS  PubMed  Google Scholar 

  65. Meerwaldt R, Odink RJ, Landaeta R, Aarts F, Brunekreef B, Gerritsen J, et al. A lower prevalence of atopy symptoms in children with type 1 diabetes mellitus. Clin Exp Allergy. 2002;32:254–5.

    Article  CAS  PubMed  Google Scholar 

  66. Rosenbauer J, Herzig P, Giani G. Atopic eczema in early childhood could be protective against type 1 diabetes. Diabetologia. 2003;46:784–8.

    Article  CAS  PubMed  Google Scholar 

  67. Stene LC, Joner G. Atopic disorders and risk of childhood-onset type 1 diabetes in individuals. Clin Exp Allergy. 2004;34:201–6.

    Article  CAS  PubMed  Google Scholar 

  68. Siemiatycki J, Colle E, Campbell S, Dewar RA, Belmonte MM. Case-control study of IDDM. Diabetes Care. 1989;12:209–16.

    Article  CAS  PubMed  Google Scholar 

  69. Mattila PS, Tarkkanen J, Saxen H, Pitkäniemi J, Karvonen M, Tuomilehto J. Predisposition to atopic symptoms to inhaled antigens may protect from childhood type 1 diabetes. Diabetes Care. 2002;25:865–8.

    Article  PubMed  Google Scholar 

  70. Kero J, Gissler M, Hemminki E, Isolauri E. Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol. 2001;108:781–3.

    Article  CAS  PubMed  Google Scholar 

  71. Simpson CR, Anderson WJ, Helms PJ, Taylor MW, Watson L, Prescott GJ, et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy. 2002;32:37–42.

    Article  CAS  PubMed  Google Scholar 

  72. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet. 2001;357:607–8.

    Article  CAS  PubMed  Google Scholar 

  73. Stromberg LG, Ludvigsson GJ, Bjorksten B. Atopic allergy and delayed hypersensitivity in children with diabetes. J Allergy Clin Immunol. 1995;96:188–92.

    Article  CAS  PubMed  Google Scholar 

  74. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787–93.

    Article  CAS  PubMed  Google Scholar 

  75. Simon D. Epidemiological features of type 2 diabetes. Rev Prat. 2010;60:469–73.

    PubMed  Google Scholar 

  76. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24:237–46.

    Article  PubMed  Google Scholar 

  77. Henry J, Toulza E, Hsu CY, Pellerin L, Balica S, Mazereeuw-Hautier J, et al. Update on the epidermal differentiation complex. Front Biosci. 2012;17:1517–32.

    Article  CAS  Google Scholar 

  78. Thyssen JP, Thuesen B, Huth C, Standl M, Carson CG, Heinrich J, et al. Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. J Allergy Clin Immunol. 2012;130:1204–7.

    Article  CAS  PubMed  Google Scholar 

  79. Proceedings of the 4th international workshop-conference on gestational diabetes mellitus, Chicago, 14–16 Mar 1997. Diabetes Care. 1998;21 Suppl 2:B1-167.

    Google Scholar 

  80. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–8.

    Article  PubMed  Google Scholar 

  81. Jarvela IY, Juutinen J, Koskela P, Hartikainen AL, Kulmala P, Knip M, et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care. 2006;29:607–12.

    Article  CAS  PubMed  Google Scholar 

  82. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.

    Article  CAS  PubMed  Google Scholar 

  83. Kumar R, Ouyang F, Story RE, Pongracic JA, Hong X, Wang G, et al. Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood. J Allergy Clin Immunol. 2009;124:1031–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgment

Elena Godoy-Gijón was funded by an unrestricted research grant from ISDIN as a part of a national Spanish award.

Author information

Authors and Affiliations

  1. Department of Dermatology, Hospital De Cabueñes, Secretaría del Servicio de Dermatología, Policlínicas de la Casa del Mar, Avda. Príncipe de Asturias, 76, Gijón, Asturias, 33212, Spain

    Elena Godoy-Gijón MD

Authors
  1. Elena Godoy-Gijón MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Godoy-Gijón MD .

Editor information

Editors and Affiliations

  1. Department of Dermato-Allergology, National Allergy Research Centre, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

    Jacob P. Thyssen

  2. Department of Dermatology, University of California, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Godoy-Gijón, E. (2014). Filaggrin, the Skin Barrier, and Diabetes. In: Thyssen, J., Maibach, H. (eds) Filaggrin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54379-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54379-1_30

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54378-4

  • Online ISBN: 978-3-642-54379-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation